Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
about
Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding proteinThe lipocalin protein family: structure and functionBinding of perlecan to transthyretin in vitroComplex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursorMechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisVitamin A Transport Mechanism of the Multitransmembrane Cell-Surface Receptor STRA6Role of conserved residues in structure and stability: Tryptophans of human serum retinol-binding protein, a model for the lipocalin superfamilyDistinctive binding and structural properties of piscine transthyretinToward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies †Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding proteinIdentification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in VivoToward Optimization of the Second Aryl Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies †Amyloidogenic Potential of Transthyretin Variants: INSIGHTS FROM STRUCTURAL AND COMPUTATIONAL ANALYSESNovel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural AnalysisA Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and CytotoxicityChemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasmaPotent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte ProteotoxicityThe structure ofSerratia marcescensLip, a membrane-bound component of the type VI secretion systemAromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent ConjugateAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinTafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeBifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensorsFluorogenic small molecules requiring reaction with a specific protein to create a fluorescent conjugate for biological imaging-what we know and what we need to learnStructural evidence for asymmetric ligand binding to transthyretinInhibiting transthyretin conformational changes that lead to amyloid fibril formationTertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formationMolecular Basis for Vitamin A Uptake and Storage in VertebratesEvolving landscape in the management of transthyretin amyloidosisRepurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialTranscriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1)Vitamin A transport and the transmembrane pore in the cell-surface receptor for plasma retinol binding proteinAn odorant-binding protein is abundantly expressed in the nose and in the seminal fluid of the rabbitThe transfer of transthyretin and receptor-binding properties from the plasma retinol-binding protein to the epididymal retinoic acid-binding protein.Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.Unique biochemical nature of carp retinol-binding protein. N-linked glycosylation and uncleavable NH2-terminal signal peptide.Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasisTafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trialSupport for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
P2860
Q24315891-9290B441-00CD-4EDE-9A10-EEA80C24EE30Q24529878-1D4DF21C-AA6E-4701-8F9A-DBC994043374Q24530380-CEF29989-3767-442D-AB0F-BE6B1EF3C787Q24531496-34B2DA09-A372-4475-83CC-20F0C9010BB2Q26764754-1F217D0F-3CB9-4DD7-B1A1-C0C3B9D6B80CQ26783584-33644DF0-4460-4F0D-8E81-F7EF4EB7055AQ27635444-053D4A54-5042-4F83-BE4A-1AB88D9B697EQ27642654-7E9EDB12-E0BA-4538-9EA9-D438854D4BABQ27652272-B33140F0-95C1-410A-A673-990AFDD2B94FQ27652955-07EFAAE3-2249-4629-8E94-E21406E4F8B2Q27653437-8C3EBDB1-F1EB-4AF2-9117-AB7A28B742A8Q27653642-1D71E953-82F1-47D7-A99E-6C71DBE4938DQ27656412-3A800B87-97FA-47A5-887A-DA43490F6715Q27656578-C47FD91F-D130-4147-80E6-85F08F183587Q27658823-D42BF72A-36E6-40ED-8C88-396A4CE8935CQ27659009-696CA232-C0F0-43D7-8979-B34DA7D4C765Q27671971-D9B6266A-80F2-45F7-97E1-0C8F12BA340AQ27675845-F80F7ECD-185E-49F0-9D50-F3B77340C6F3Q27675997-E89ECEB8-C166-4846-81D3-DDEBD393B000Q27678369-67029206-CA16-4C7E-924B-842DBC17FB56Q27679360-04EEE7BB-1BCE-4DC6-A79F-7CF28F1CE9C9Q27679824-74FC70C5-C12C-49CE-A29C-C5E9F9866987Q27680199-55A4E39C-1361-42F2-9B61-1EC85E87A732Q27701741-CF4FB788-05BA-44CE-9F41-EDFA97B03602Q27765742-3DF91F31-69A5-4E7E-8C56-AF28BE37F0A8Q27766043-AB7CE6EF-4F31-48CC-8000-611EEED7AACAQ28076290-493DA529-0869-443E-BF04-EB3DA8CCF6F5Q28086773-06847CE4-C6D0-448D-817B-6FB48FD17FA3Q28304712-D7052B65-5E9B-4B23-B27E-928D9DB8AB4DQ28510034-51968B01-D1C9-4D16-920C-270048DD7CC5Q28534788-EA47D43E-1F9D-4FC8-A8EE-3618F004AA29Q28544889-E4DA3178-FE9A-4C2A-9DAD-4199F413B485Q30167591-27A1F6D8-068D-4C92-877D-8C518C576491Q30175852-88AD4E54-2D81-4FD8-AFBB-6CA2F3355BD4Q30661447-8D7F56EC-3E72-4012-8D6C-C5DDCC4E1D5BQ33358097-5F0CEFF2-A0CF-41BB-899E-8E64BE8B2982Q33449878-AFB14734-38CA-4B95-8647-761B7502AD68Q33903527-87E91656-D52E-4A57-ABE4-3C19CDEA6533Q33949040-8D668336-0554-4DF4-84C5-6ECCB6255C5BQ33952780-370440A0-C95B-4322-B4DB-CA51BAD2CBAE
P2860
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@ast
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@en
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@nl
type
label
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@ast
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@en
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@nl
prefLabel
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@ast
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@en
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@nl
P356
P1433
P1476
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
@en
P304
P356
10.1126/SCIENCE.7754382
P407
P577
1995-05-01T00:00:00Z